{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:38:58Z","timestamp":1792532338956,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate potential alterations in retinal microvasculature among users of selective serotonin reuptake inhibitors (SSRIs) using optical coherence tomography angiography, and to compare the vascular effects across different SSRI subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This observational cross-sectional study included 111 patients on SSRIs for at least three months and 95 age- and sex-matched healthy controls. All participants underwent comprehensive ophthalmic examinations and optical coherence tomography angiography imaging with a 3 \u00d7 3-mm macular scan. Vascular densities in the superficial capillary plexus, deep capillary plexus (DCP), and foveal avascular zone (FAZ) area were quantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Compared with controls, SSRI users exhibited significantly reduced vascular density in most regions of the superficial capillary plexus and all regions of the DCP (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), along with an enlarged FAZ area. The duration of SSRI use showed a significant negative correlation with vascular density in multiple regions. Among different SSRIs, escitalopram users had significantly lower central DCP density compared with users of fluoxetine, paroxetine, and sertraline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Chronic use of SSRIs has been associated with measurable reductions in retinal vascular density and enlargement of the FAZ, which may reflect microvascular compromise. Escitalopram seems to demonstrate a more pronounced vascular effect in comparison with other SSRIs. These findings highlight the significance of retinal vascular evaluation in patients undergoing long-term SSRI therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004978","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:00:25Z","timestamp":1787320825000},"page":"2050-2055","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["VISUALIZING VASCULAR EFFECTS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-5560","authenticated-orcid":false,"given":"Yusuf B.","family":"Akbas","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cengiz","family":"Gul","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Ozal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet B.","family":"Ozyurek","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer S.","family":"Guler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Serikoglu Akbas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bak\u0131rk\u00f6y Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahri O.","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ceylan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcin K.","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/164_2018_172","article-title":"Selective serotonin reuptake inhibitors","volume":"250","author":"Lochmann","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"R2-20261020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2018.11.006","article-title":"Serotonin in retina","volume":"161","author":"Masson","year":"2019","journal-title":"Biochimie"},{"key":"R3-20261020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/01.WNL.0000154523.21633.0E","article-title":"SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage","volume":"64","author":"Singhal","year":"2005","journal-title":"Neurology"},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OPTO.S355091","article-title":"A review of ocular complications associated with medications used for anxiety, depression, and stress","volume":"14","author":"Constable","year":"2022","journal-title":"Clin Optom"},{"key":"R5-20261020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","article-title":"Optical coherence tomography angiography","volume":"64","author":"Spaide","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4274\/tjo.43.67944","article-title":"Psychotropic drugs and ocular side effects","volume":"43","author":"S\u00f6nmez","year":"2013","journal-title":"T\u00fcrk Oftalmoloji Dergisi"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3399\/bjgp16X683641","article-title":"Keep an eye on the SSRI: help avoid possible sight-threatening adverse events","volume":"66","author":"Lochhead","year":"2016","journal-title":"Br J Gen Pract"},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15569527.2017.1330270","article-title":"Effects of selective serotonin reuptake inhibitors on intraocular pressure and anterior segment parameters in open angle eyes","volume":"37","author":"G\u00fcnd\u00fcz","year":"2018","journal-title":"Cutan Ocul Toxicol"},{"key":"R9-20261020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00023210-200418080-00001","article-title":"SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms","volume":"18","author":"Costagliola","year":"2004","journal-title":"CNS Drugs"},{"key":"R10-20261020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/eye.1999.196","article-title":"Paroxetine and acute angle-closure glaucoma","volume":"13(Pt 5)","author":"Bennett","year":"1999","journal-title":"Eye"},{"key":"R11-20261020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157015908787386104","article-title":"Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure","volume":"6","author":"Costagliola","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"R12-20261020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JRS-210018","article-title":"Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants","volume":"33","author":"Healy","year":"2022","journal-title":"Int J Risk Saf Med"},{"key":"R13-20261020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1034\/j.1600-0420.2001.079004428.x","article-title":"Presumed sertraline maculopathy","volume":"79","author":"\u015eener","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"R14-20261020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/02713683.2017.1420198","article-title":"Effects of selective serotonin reuptake inhibitors on macular ganglion cell complex thickness and peripapillary retinal nerve fiber layer thickness","volume":"43","author":"Guclu","year":"2018","journal-title":"Curr Eye Res"},{"key":"R15-20261020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-001-0993-y","article-title":"Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes","volume":"160","author":"Schmitt","year":"2002","journal-title":"Psychopharmacology"},{"key":"R16-20261020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/exer.1999.0773","article-title":"Effect of fluoxetine on intraocular pressure in the rabbit","volume":"70","author":"Costagliola","year":"2000","journal-title":"Exp Eye Res"},{"key":"R17-20261020","first-page":"308","article-title":"Do beta-adrenoceptors and serotonin 5-HT1A receptors have similar functions in the control of intraocular pressure in the rabbit?","volume":"210","author":"Osborne","year":"1996","journal-title":"Ophthalmologica"},{"key":"R18-20261020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1471-4159.1989.tb11758.x","article-title":"Evidence for the presence of serotonin receptors negatively coupled to adenylate cyclase in the rabbit iris\u2010ciliary body","volume":"53","author":"Tobin","year":"1989","journal-title":"J Neurochem"},{"key":"R19-20261020","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00213-017-4545-5","article-title":"A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment","volume":"234","author":"Palacios","year":"2017","journal-title":"Psychopharmacology"},{"key":"R20-20261020","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ICU.0000000000000001","article-title":"Toxic optic neuropathies","volume":"24","author":"Altiparmak","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R21-20261020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/eye.2015.119","article-title":"SSRI-associated optic neuropathy","volume":"29","author":"Lochhead","year":"2015","journal-title":"Eye"},{"key":"R22-20261020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.14744\/eer.2024.80775","article-title":"Selective serotonin reuptake inhibitors and ocular health: analyzing retinal and choroidal thickness variations","volume":"4","author":"Yilmaz","year":"2024","journal-title":"Eur Eye Res"},{"key":"R23-20261020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/YIC.0000000000000023","article-title":"A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?","volume":"29","author":"Sanchez","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"R24-20261020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/11206721241228620","article-title":"Evaluation of retinal and choroidal vascular structures in patients with anxiety disorder","volume":"34","author":"Acan","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"R25-20261020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/ejos.ejos_26_24","article-title":"Retinal morphology and microvasculature density alterations in generalized anxiety disorders","volume":"117","author":"Abdala","year":"2024","journal-title":"J Egypt Ophthalmol Soc"},{"key":"R26-20261020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pscychresns.2016.04.011","article-title":"Duration of the depressive episode is correlated with ganglion cell inner plexifrom layer and nasal retinal fiber layer thicknesses: optical coherence tomography findings in major depression","volume":"251","author":"Y\u0131ld\u0131z","year":"2016","journal-title":"Psychiatry Res Neuroimaging"},{"key":"R27-20261020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5152\/npa.2015.10115","article-title":"Retinal nerve fiber layer thickness measurement by spectral-domain optical coherence tomography in patients with major depressive disorder","volume":"54","author":"S\u00f6nmez","year":"2017","journal-title":"Noro Psikiyatr Ars"},{"key":"R28-20261020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jad.2024.06.039","article-title":"Optical coherence tomography angiography in patients with bipolar disorder and major depressive disorder","volume":"361","author":"Zinchuk","year":"2024","journal-title":"J Affect Disord"},{"key":"R29-20261020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jad.2023.10.022","article-title":"Choroidal vessel density in major depressive disorder using swept-source optical coherence tomography angiography","volume":"344","author":"Wang","year":"2024","journal-title":"J Affect Disord"},{"key":"R30-20261020","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2147\/PRBM.S443146","article-title":"Association of retinal neurovascular impairment with disease severity in patients with major depressive disorder: an optical coherence tomography angiography study","volume":"17","author":"Wang","year":"2024","journal-title":"Psychol Res Behav Manag"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:00:24Z","timestamp":1792530024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004978"}},"subtitle":["An OCT Angiography Perspective"],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004978","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11]]}}}